BIO Commends Senate for Approval of User Fee Package – Business Wire
WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO)Â President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. Senate ...
Subscribe to LegalLaw247.Com Newsletter